J.Jpn. Surg. Soc.
ISSN 1880-1129

[Abstract] [Full Text PDF] （in Japanese / 1728KB） [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 92(9): 1147-1150, 1991

Report on the annual meeting

BONE MARROW TRANSPLANTATION FOR PEDIATRIC SOLID TUMOR

Department of Surgery, Tokai University, School of Medicine, Isehara, Japan

Seishichi Yokoyama, Hitoshi Hirakawa, Tomoo Tajima, Toshio Mitomi, Hiromasa Yabe, Miharu Yabe, Shunichi Kato

Bone marrow transplantation permits the use of greartly intensified cytoreductive therapy for cancer. Since 1981, fifteen children with disseminated solid tumor were treated by this method (6 Nb1, 6 Lymphoma, 1 PNET, 1 Hb1, 1 YST.). Eight out of 15 (53%) have been alive and well 2-96 (median 45) months after BMT. Though toxicity is severe, high dose chemo-radiotherapy using BMT after reaching complete remission with well scheduled induction chemotherapy and surgery is concluded as a treatment of choice for pediatric malignant solid tumor in advanced stage.

<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.